Currently, Cyclerion Therapeutics Inc’s (CYCN) stock is trading at $3.97, marking a gain of 56.20% from last night’s close. At this price, the stock is -58.10% below its 52-week high of $9.47 and 212.40% above its 52-week low of $1.27. Based on the past 30-day period, the stock price is -5.14% below the high and +84.35% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CYCN’s SMA-200 is $2.87.
As well, it is important to consider CYCN stock ratios such as price-to-sales, which is currently 56.56.CYCN’s price to book ratio for the most recent quarter was 1.22, resulting in an 3.74 price to cash per share for the period.
How does Cyclerion Therapeutics Inc (CYCN) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
Cyclerion Therapeutics Inc (NASDAQ: CYCN) Ownership Details
I will give a breakdown of the key shareholders in Cyclerion Therapeutics Inc (CYCN). Recent figures show that the company’s insiders hold 21.90% of shares. A total of 17 institutional investors hold shares in the company, making 40.41% of its stock and 51.74% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Slate Path Capital, LP holding total of 357.88 shares that make 13.21% of the company’s total number of shares and are currently priced at 1.34 million.
The securities firm MFN Partners Management, LP holds 169.46 shares of CYCN, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 6.25%, and the holding percentage of shares is valued at 0.63 million.
An overview of Cyclerion Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Cyclerion Therapeutics Inc (CYCN) traded 1,496,772 shares per day, with a moving average of $3.01 and price change of +1.02. With the moving average of $3.00 and a price change of +1.66, about 4,277,455 shares changed hands on average over the past 50 days. Finally, CYCN’s 100-day average volume is 2,268,506 shares, alongside a moving average of $2.84 and a price change of +1.31.
